Two recent studies indicate that CBD could be a valuable tool for fighting the opioid epidemic.

Federal health minister Jane Philpott has described the opioid epidemic as the “greatest public health crisis we face in Canada.” One new study suggests cannabis could be effective in treating opioid addiction through substitution therapy, while another recent study links CBD to the inhibition of opioid rewards in the brain.

In 2016, a public health emergency was declared in British Columbia due to the alarming rate of drug overdose deaths stemming from widespread overuse of prescription opioid painkillers, and an influx of illicit narcotics laced with deadly fentanyl and carfentanil.

Lawmakers in about two dozen states have proposed bills this year to ease their marijuana laws despite Attorney General Jeff Sessions' warning that he could crack down on pot, a major change from the Obama administration, which essentially turned a blind eye to the state legislation.

Bills have been introduced in 17 states this year to make recreational pot legal for adults, while five others are considering voter referendums on the issue. Sixteen states have introduced medical marijuana legislation, 10 are considering decriminalizing the drug and three are considering easing their penalties. An effort in Wyoming to decriminalize the drug failed this session.

When Proposition 64 passed in California, legalizing recreational marijuana use, many people imagined that UC Davis might get into the pot business. With the No. 1 agricultural school in the nation, as well as a top plant biology program, UCD seems poised to become a cannabis research leader.

Not so fast, says Chief Campus Counsel Jacob Appelsmith.

“Under federal law, (marijuana) is a Schedule 1 drug,” Appelsmith said, as are heroin and LSD. Even as states are legalizing cannabis for both medical and recreational uses, the feds are not moving forward at the same pace.

Though the US Drug Enforcement Agency hasn’t reclassified marijuana, easier availability of the drug for study has the potential to unearth new medical uses.

Companies that make prescription painkillers and their allies have contributed more than $366,000 to Mississippi candidates and hired an average of 18 lobbyists yearly in the state since 2006 to push their policies.

The spending comes as Mississippi's use of opioids reached the fifth-highest in the country last year.

A joint investigation by The Associated Press and the Center for Public Integrity found the organizations spent $880 million nationwide and hired an annual average of 1,350 lobbyists in state capitals around the country from 2006 through 2015. By comparison, groups seeking limits on opioid prescribing spent about $4 million.
 

Wanted: Someone to grow marijuana for the federal government. Benefits: A contract likely worth millions and the chance to enable medical research. Requirements: Ability to deal with the costs and regulations that come with growing an illegal drug for the federal government.

More questions than answers from a new study out of The Netherlands.

Recent studies suggest that there could be differences in brain thickness between children who are exposed to cannabis and those who aren’t — but do these studies tell the whole story?

Across the pond, an hour south from Amsterdam, Dr. Hanan El Marroun, of Erasmus University Medical Center in The Netherlands has dedicated his work to researching one of the most overlooked aspects of cannabis use: consuming while pregnant.